WINTON GROUP Ltd Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

WINTON GROUP Ltd bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,012 shares of the healthcare conglomerate’s stock, valued at approximately $1,018,000.

A number of other institutional investors have also bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of UnitedHealth Group by 6.1% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,740,072 shares of the healthcare conglomerate’s stock worth $1,405,662,000 after buying an additional 156,851 shares in the last quarter. Foundation Wealth Management LLC PA bought a new position in UnitedHealth Group during the fourth quarter worth $835,000. Tyler Stone Wealth Management increased its stake in UnitedHealth Group by 6.7% in the fourth quarter. Tyler Stone Wealth Management now owns 1,365 shares of the healthcare conglomerate’s stock valued at $691,000 after purchasing an additional 86 shares in the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its stake in shares of UnitedHealth Group by 42.8% in the 4th quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 117,588 shares of the healthcare conglomerate’s stock valued at $59,483,000 after buying an additional 35,259 shares during the period. Finally, Aviso Wealth Management raised its stake in UnitedHealth Group by 59.2% during the 4th quarter. Aviso Wealth Management now owns 1,328 shares of the healthcare conglomerate’s stock worth $672,000 after buying an additional 494 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of recent research reports. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Down 0.0 %

Shares of NYSE UNH opened at $515.47 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business’s fifty day moving average price is $508.81 and its 200-day moving average price is $544.24. The stock has a market capitalization of $471.51 billion, a PE ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.